Phil Greer<p>I have worked on a lot of papers, this is my first preprint. </p><p>Analyzing large biobanks of genomic data requires a fresh look at our quality control metrics, especially as we move to NGS and more diverse populations.</p><p>You may be throwing out biologically important variants.</p><p>I would be happy to hear feedback.</p><p><a href="https://genomic.social/tags/UKBiobank" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UKBiobank</span></a> <a href="https://genomic.social/tags/HardyWeinbergEquilibrum" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HardyWeinbergEquilibrum</span></a> <br><a href="https://genomic.social/tags/statistics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>statistics</span></a> <a href="https://genomic.social/tags/statisticalgenetics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>statisticalgenetics</span></a> <a href="https://genomic.social/tags/GWAS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GWAS</span></a> <a href="https://genomic.social/tags/genetics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>genetics</span></a> <a href="https://genomic.social/tags/preprint" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>preprint</span></a> </p><p><a href="https://www.medrxiv.org/content/10.1101/2024.02.07.24301951v1" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">medrxiv.org/content/10.1101/20</span><span class="invisible">24.02.07.24301951v1</span></a></p>